Clinical Implications of VEGF, TGF-beta1, and IL-1beta in Patients with Advanced Non-small Cell Lung Cancer
Cancer Research and Treatment. 2013;45(4):325-333 
Pathologic complete response in advanced non-small-cell lung cancer following preoperative chemotherapy: Implications for the design of future non-small-cell lung cancer combined modality trials
Lung Cancer. 1994;11(1-2):144
Four Platinum Based Doublets in Patients with Advanced Non–Small-Cell Lung Cancer: Preliminary Results of PS2 Patients
Clinical Lung Cancer. 1999;1(1):29-30
Chemotherapy Regimens in Advanced Non–Small-Cell Lung Cancer: Implications and Future Perspectives
Clinical Lung Cancer. 2000;2:S7-S10
Treatment of Patients with Advanced Non-Small Cell Lung Cancer
Lung Cancer. 2003;158-185
Successful Crizotinib Rechallenge After Crizotinib-Induced Interstitial Lung Disease in Patients With Advanced Non–Small-Cell Lung Cancer
Clinical Lung Cancer. 2014;15(3):e33-e35
Management of Advanced Non–Small-Cell Lung Cancer in Elderly Populations
Clinical Lung Cancer. 2003;5(3):169-173
Emerging Safety Data for Bevacizumab in Advanced Non–Small-Cell Lung Cancer
Clinical Lung Cancer. 2008;9:S62-S70
Irinotecan/Taxane Combinations in Advanced Non–Small-Cell Lung Cancer
Clinical Lung Cancer. 2002;4:S10-S14
Molecular biologic features of non-small cell lung cancer. Clinical implications
Lung Cancer. 1995;13(2):232